Alpha-9 Oncology

Alpha-9 Oncology is a clinical-stage radiopharmaceutical company developing targeted radioligand therapies and imaging agents to treat solid and hematologic cancers with high precision. Founded in 2019 and backed by Lightspeed Venture Partners, the company engineers each molecule — binder, linker, chelator, and radioisotope — through a bespoke, iterative optimization process, and is advancing a pipeline that includes the A9-3202 imaging agent and the Actinium-225-based therapeutic A9-3408 into clinical trials. Alpha-9 is a therapeutics company with no public developer API, developer portal, or SDKs; it was surfaced in the API Evangelist network as a venture-portfolio lead from Lightspeed Venture Partners.

Alpha-9 Oncology is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Oncology, Radiopharmaceuticals, and Pharmaceuticals.

Alpha-9 Oncology’s developer surface includes support, engineering blog, and 4 more developer resources.

🌐 Visit website 📡 Source on GitHub

13.0/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyBiotechnologyOncologyRadiopharmaceuticalsPharmaceuticalsHealthcareClinical-StagePrecision Medicine

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 13.0/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 1.3 / 20

Commercial Clarity 4.2 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/alpha9: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

TermsOfService

TermsOfService

Company 3

The organization behind the API

Website

Website

Blog

Blog

LinkedIn

Source (apis.yml)

aid: alpha9
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/alpha9.png
name: Alpha-9 Oncology
description: Alpha-9 Oncology is a clinical-stage radiopharmaceutical company developing targeted radioligand therapies and
  imaging agents to treat solid and hematologic cancers with high precision. Founded in 2019 and backed by Lightspeed Venture
  Partners, the company engineers each molecule — binder, linker, chelator, and radioisotope — through a bespoke, iterative
  optimization process, and is advancing a pipeline that includes the A9-3202 imaging agent and the Actinium-225-based therapeutic
  A9-3408 into clinical trials. Alpha-9 is a therapeutics company with no public developer API, developer portal, or SDKs;
  it was surfaced in the API Evangelist network as a venture-portfolio lead from Lightspeed Venture Partners.
url: https://raw.githubusercontent.com/api-evangelist/alpha9/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- lightspeed-venture-partners
x-tier: stub
x-tier-reason: no-api-surface-biotech
x-industry: healthcare-biotechnology
x-enrichment-note: Enrichment run 2026-07-17 confirmed Alpha-9 Oncology is a clinical-stage biotech (radiopharmaceuticals).
  No developer API, OpenAPI, SDKs, MCP, or technical surface exists. Only real, published identity/link properties were captured;
  no API artifacts were fabricated.
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-17'
tags:
- Company
- Biotechnology
- Oncology
- Radiopharmaceuticals
- Pharmaceuticals
- Healthcare
- Clinical-Stage
- Precision Medicine
apis: []
common:
- type: Website
  url: https://a9oncology.com
- type: Support
  url: https://www.a9oncology.com/contact/
- type: Blog
  url: https://www.a9oncology.com/news/
- type: PrivacyPolicy
  url: https://www.a9oncology.com/privacy-policy/
- type: TermsOfService
  url: https://www.a9oncology.com/terms-of-use/
- type: LinkedIn
  url: https://www.linkedin.com/company/alpha9tx
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence